Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
United States
USC/Norris Comprehensive Cancer Center, Los Angeles, California UC Irvine Health, Orange, California University of Miami, Miami, Florida Community Health Network, Indianapolis, Indiana UPMC- Hillman Cancer Center, Pittsburgh, Pennsylvania Mary Crowley Cancer Research, Dallas, Texas University of Texas MD Anderson Cancer Center, Houston, Texas